AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation